-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeted Medical Therapies for Vascular Anomalies

Program: Education Program
Session: Vascular Anomalies, Vascular Malformations, and the Role of the Hematologist
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Chemotherapy, Treatment Considerations, Adverse Events, Non-Biological therapies
Monday, December 9, 2024, 4:30 PM-5:45 PM

Alexandra Jane Borst, MD

Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC

Disclosures: Borst: Novartis: Consultancy.

OffLabel Disclosure: Most of the drugs I discuss in this paper and talk are used off-label for treatment of vascular anomalies

See more of: Vascular Anomalies, Vascular Malformations, and the Role of the Hematologist
See more of: Education Program
<< Previous Presentation | Next Presentation >>